Inspire Veterinary Partners, Inc.(IVP)Earnings, Financials & Key Ratios
IVP•NASDAQ
$0.03
$102706 mkt cap·Price updated May 1, 2026
AboutInspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.Show more
- Revenue$17M-0.5%
- EBITDA-$7M-27.8%
- Net Income-$14M+3.6%
- EPS (Diluted)-2.61+100.0%
- Gross Margin19.84%-6.9%
- EBITDA Margin-44.35%-28.4%
- Operating Margin-54.41%-26.4%
- Net Margin-85.97%+3.1%
- ROE-3687.07%
- ROIC-38.84%-28.1%
- Debt/Equity10.48
- Interest Coverage-2.91-3.1%
IVP Key Insights
Inspire Veterinary Partners, Inc. (IVP) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.1x book value
✗Weaknesses
- ✗High debt to equity ratio of 10.5x
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 4 (bottom 4%)
- ✗Shares diluted 100.0% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
IVP Price & Volume
Inspire Veterinary Partners, Inc. (IVP) stock price & volume — 10-year historical chart
Loading chart...
IVP Growth Metrics
Inspire Veterinary Partners, Inc. (IVP) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years86.71%
TTM-8.76%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM17.29%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM99.6%
Return on Capital
10 Years-62.96%
5 Years-62.96%
3 Years-54.17%
Last Year-68.89%
IVP Peer Comparison
Inspire Veterinary Partners, Inc. (IVP) competitors in Pet Care and Veterinary Services — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 TRUP | 1.08B | 24.94 | 55.42 | 11.95% | 1.74% | 6.87% | 0.29 | |
 PETS | 48.55M | 2.31 | -7.70 | -17.19% | -28.22% | -127.77% | 0.01 | |
 WOOF | 749.14M | 2.74 | 86.44 | -2.53% | 0.15% | 0.79% | 1.18 | |
 BARK | 77.43M | 8.96 | -2.36 | -1.22% | -7.65% | -35.9% | 0.86 | |
 FRPT | 2.69B | 54.93 | 20.80 | 13.01% | 17.63% | 16.98% | 0.46 | |
 IDXX | 46.12B | 579.23 | 44.28 | 10.42% | 24.63% | 70.87% | 0.67 | |
 ZTS | 46.95B | 111.22 | 18.48 | 2.28% | 28.23% | 58.23% | 2.85 | |
 ELAN | 13.06B | 26.16 | -55.66 | 6.22% | -4.95% | -3.64% | 0.61 |
Compare IVP vs Peers
Inspire Veterinary Partners, Inc. (IVP) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
IVP Income Statement
Inspire Veterinary Partners, Inc. (IVP) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 2.55M | 9.83M | 16.68M | 16.59M | 15.56M |
| Revenue Growth % | - | - | 285.81% | 69.56% | -0.5% | -8.76% |
| Cost of Goods Sold | 0 | 1.72M | 7.29M | 13.12M | 13.3M | 10.83M |
| COGS % of Revenue | - | 67.47% | 74.12% | 78.69% | 80.16% | - |
| Gross Profit | 0▲ 0% | 829.29K▲ 0% | 2.55M▲ 207.0% | 3.55M▲ 39.6% | 3.29M▼ 7.4% | 4.73M▲ 0% |
| Gross Margin % | - | 32.53% | 25.88% | 21.31% | 19.84% | 30.43% |
| Gross Profit Growth % | - | - | 206.96% | 39.61% | -7.35% | - |
| Operating Expenses | 5.52K | 1.88M | 6.06M | 10.73M | 12.32M | 12.86M |
| OpEx % of Revenue | - | 73.61% | 61.66% | 64.34% | 74.25% | - |
| Selling, General & Admin | 5.52K | 1.79M | 5.47M | 9.48M | 11.42M | 10.89M |
| SG&A % of Revenue | - | 70.3% | 55.6% | 56.83% | 68.84% | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 84.47K | 596.12K | 1.25M | 898.23K | 1.28M |
| Operating Income | -5.52K▲ 0% | -1.05M▼ 18871.4% | -3.52M▼ 235.9% | -7.17M▼ 103.9% | -9.03M▼ 25.8% | -8.13M▲ 0% |
| Operating Margin % | - | -41.08% | -35.77% | -43.03% | -54.41% | -52.22% |
| Operating Income Growth % | - | -18871.39% | -235.95% | -103.94% | -25.81% | - |
| EBITDA | 0 | -962.76K | -2.91M | -5.76M | -7.36M | -6.83M |
| EBITDA Margin % | - | -37.77% | -29.57% | -34.54% | -44.35% | -43.88% |
| EBITDA Growth % | - | - | -202.11% | -98.04% | -27.77% | 19.17% |
| D&A (Non-Cash Add-back) | 5.52K | 84.47K | 609.59K | 1.41M | 1.67M | 1.3M |
| EBIT | -5.52K | -1.06M | -3.52M | -12.25M | -11.17M | -9.66M |
| Net Interest Income | 0 | -194.65K | -1.42M | -2.54M | -3.1M | -1.68M |
| Interest Income | 0 | 161 | 1.02K | 21 | 53 | 32 |
| Interest Expense | 0 | 194.81K | 1.43M | 2.54M | 3.1M | 1.68M |
| Other Income/Expense | 0 | -209.51K | -1.42M | -7.62M | -5.24M | -3.82M |
| Pretax Income | -5.52K▲ 0% | -1.26M▼ 22666.9% | -4.94M▼ 293.2% | -14.79M▼ 199.3% | -14.26M▲ 3.6% | -11.94M▲ 0% |
| Pretax Margin % | - | -49.3% | -50.25% | -88.71% | -85.97% | -76.75% |
| Income Tax | 0 | 74.33K | -30.09K | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -5.91% | 0.61% | 0% | 0% | 0% |
| Net Income | -5.52K▲ 0% | -1.33M▼ 24013.4% | -4.91M▼ 269.0% | -14.79M▼ 201.2% | -14.26M▲ 3.6% | -11.94M▲ 0% |
| Net Margin % | - | -52.22% | -49.94% | -88.71% | -85.97% | -76.75% |
| Net Income Growth % | - | -24013.44% | -269.02% | -201.16% | 3.57% | 17.29% |
| Net Income (Continuing) | -5.52K | -1.33M | -4.91M | -14.79M | -14.26M | -11.94M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.00▲ 0% | -297.85▲ 0% | -1099.13▼ 269.0% | -5627.23▼ 412.0% | -2.61▲ 100.0% | -1.96▲ 0% |
| EPS Growth % | - | - | -269.02% | -411.97% | 99.95% | 99.6% |
| EPS (Basic) | 0.00 | -297.85 | -1099.13 | -5627.23 | -2.61 | - |
| Diluted Shares Outstanding | 4.47K | 4.47K | 4.47K | 2.68K | 5.55M | 6.09M |
| Basic Shares Outstanding | 4.47K | 4.47K | 4.47K | 2.68K | 5.55M | 6.09M |
| Dividend Payout Ratio | - | - | - | - | - | - |
IVP Balance Sheet
Inspire Veterinary Partners, Inc. (IVP) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Total Current Assets | 21.97K | 2.39M | 1.74M | 1.35M | 2.02M | 3.82M |
| Cash & Short-Term Investments | 21.97K | 2.06M | 444.25K | 178.96K | 523.69K | 341.75K |
| Cash Only | 21.97K | 2.06M | 444.25K | 178.96K | 523.69K | 341.75K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 228.12K | 462.02K | 212.89K | 40.67K | 28.7K |
| Days Sales Outstanding | - | 32.66 | 17.15 | 4.66 | 0.89 | 1.51 |
| Inventory | 0 | 41K | 582.02K | 571.51K | 516.65K | 497.61K |
| Days Inventory Outstanding | - | 8.7 | 29.14 | 15.9 | 14.18 | 16.58 |
| Other Current Assets | 0 | 0 | 0 | 388.76K | -1 | 2.96M |
| Total Non-Current Assets | 0 | 3.94M | 18.44M | 20.44M | 18.17M | 20.13M |
| Property, Plant & Equipment | 0 | 2.04M | 8.07M | 9.57M | 8.26M | 8.59M |
| Fixed Asset Turnover | - | 1.25x | 1.22x | 1.74x | 2.01x | 1.85x |
| Goodwill | 0 | 1.61M | 7.61M | 8.15M | 8.02M | 9.09M |
| Intangible Assets | 0 | 239.19K | 2.73M | 2.51M | 1.63M | 1.18M |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 51.25K | 29.46K | 212.9K | 254K | 2M |
| Total Assets | 21.97K▲ 0% | 6.33M▲ 28710.9% | 20.19M▲ 218.9% | 21.79M▲ 8.0% | 20.2M▼ 7.3% | 23.96M▲ 0% |
| Asset Turnover | - | 0.40x | 0.49x | 0.77x | 0.82x | 0.73x |
| Asset Growth % | - | 28710.94% | 218.9% | 7.95% | -7.32% | -17.13% |
| Total Current Liabilities | 0 | 2M | 7.25M | 7.58M | 8.2M | 9.72M |
| Accounts Payable | 0 | 44.89K | 1.02M | 3.21M | 1.98M | 1.7M |
| Days Payables Outstanding | - | 9.53 | 51.02 | 89.2 | 54.33 | 61.75 |
| Short-Term Debt | 0 | 1.5M | 5.45M | 3.28M | 5.75M | 3.87M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | -1 | 4.15M |
| Current Ratio | - | 1.19x | 0.24x | 0.18x | 0.25x | 0.25x |
| Quick Ratio | - | 1.17x | 0.16x | 0.10x | 0.18x | 0.18x |
| Cash Conversion Cycle | - | 31.84 | -4.73 | -68.64 | -39.25 | -43.66 |
| Total Non-Current Liabilities | 0 | 5.2M | 18.07M | 15M | 10.43M | 10.07M |
| Long-Term Debt | 0 | 5.2M | 17.41M | 13.48M | 8.49M | 10.07M |
| Capital Lease Obligations | 0 | 0 | 666.18K | 1.51M | 1.94M | 5.7M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 1 | 1 |
| Total Liabilities | 0 | 7.2M | 25.32M | 22.58M | 18.63M | 19.79M |
| Total Debt | 0 | 6.69M | 23.61M | 18.42M | 16.37M | 13.94M |
| Net Debt | -21.97K | 4.64M | 23.17M | 18.24M | 15.85M | 13.6M |
| Debt / Equity | - | - | - | - | 10.48x | 10.48x |
| Debt / EBITDA | - | - | - | - | - | -2.04x |
| Net Debt / EBITDA | - | - | - | - | - | -1.99x |
| Interest Coverage | - | -5.38x | -2.47x | -2.83x | -2.91x | -5.74x |
| Total Equity | 21.97K▲ 0% | -869.09K▼ 4055.8% | -5.14M▼ 490.9% | -788.26K▲ 84.7% | 1.56M▲ 298.2% | 4.17M▲ 0% |
| Equity Growth % | - | -4055.81% | -490.9% | 84.65% | 298.16% | 1463.25% |
| Book Value per Share | 4.92 | -194.51 | -1149.39 | -294.46 | 0.28 | 0.68 |
| Total Shareholders' Equity | 21.97K | -869.09K | -5.14M | -788.26K | 1.56M | 4.17M |
| Common Stock | 435 | 515 | 528 | 389 | 419 | 662 |
| Retained Earnings | -460 | -1.33M | -6.24M | -21.22M | -36.35M | -44.33M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 |
IVP Cash Flow Statement
Inspire Veterinary Partners, Inc. (IVP) cash flow — operating, investing & free cash flow history
| Line item | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|
| Cash from Operations | -5.52K | -1.01M | -2.66M | -3.82M | -10.01M | -10.01M |
| Operating CF Margin % | - | -39.62% | -27.03% | -22.91% | -60.3% | - |
| Operating CF Growth % | - | -18196.38% | -163.21% | -43.73% | -161.88% | -553.45% |
| Net Income | -5.52K | -1.33M | -4.91M | -14.79M | -14.26M | -11.94M |
| Depreciation & Amortization | 0 | 83.91K | 609.59K | 1.41M | 1.67M | 1.42M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 23.65K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 0 | 21.04K | 1.1M | 6.6M | 5.01M | 3.31M |
| Working Capital Changes | 0 | 216.15K | 548.81K | 2.96M | -2.44M | 2.98M |
| Change in Receivables | 0 | -228.12K | -233.9K | 125.62K | 172.21K | 86.85K |
| Change in Inventory | 0 | -41K | -230.13K | 84.91K | 12.42K | 105.98K |
| Change in Payables | 0 | 44.89K | 974.04K | 2.19M | -1.23M | -373.32K |
| Cash from Investing | 0 | -4.02M | -14.67M | -1.87M | -237.98K | -1.96M |
| Capital Expenditures | 0 | -1.31M | -134.97K | -383.73K | -237.98K | -108.14K |
| CapEx % of Revenue | - | 51.41% | 1.37% | 2.3% | 1.43% | - |
| Acquisitions | 0 | -2.66M | -14.51M | -1.49M | 0 | 0 |
| Investments | - | - | - | - | - | - |
| Other Investing | 0 | -51.25K | -20.02K | 0 | 0 | -1.85M |
| Cash from Financing | 269.16K | 7.07M | 15.71M | 5.63M | 10.59M | 5.89M |
| Debt Issued (Net) | 0 | 6.84M | 15.97M | 185.44K | -3.65M | 327.43K |
| Equity Issued (Net) | 0 | 385K | 0 | 1000K | 1000K | 2M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | -650K | 0 |
| Other Financing | 269.16K | -162.73K | -260.61K | 1 | 4M | 500K |
| Net Change in Cash | 263.64K▲ 0% | 2.04M▲ 672.4% | -1.61M▼ 179.3% | -65.29K▲ 96.0% | 344.73K▲ 628.0% | -304.95K▲ 0% |
| Free Cash Flow | -5.52K▲ 0% | -2.32M▼ 41937.5% | -2.84M▼ 22.2% | -4.2M▼ 48.3% | -10.24M▼ 143.6% | -4.34M▲ 0% |
| FCF Margin % | - | -91.03% | -28.83% | -25.21% | -61.74% | -27.9% |
| FCF Growth % | - | -41937.54% | -22.18% | -48.3% | -143.64% | 57.89% |
| FCF per Share | -1.24 | -519.35 | -634.53 | -1570.60 | -1.85 | -1.85 |
| FCF Conversion (FCF/Net Income) | 1.00x | 0.76x | 0.54x | 0.26x | 0.70x | 0.36x |
| Interest Paid | 0 | 80.2K | 239.43K | 188.95K | 1.55M | 826.78K |
| Taxes Paid | 0 | 0 | 192.14K | 0 | 0 | 0 |
IVP Key Ratios
Inspire Veterinary Partners, Inc. (IVP) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|
| Return on Equity (ROE) | - | - | - | -3687.07% | -286.48% |
| Return on Invested Capital (ROIC) | -41.71% | -24.21% | -30.33% | -38.84% | -38.84% |
| Gross Margin | 32.53% | 25.88% | 21.31% | 19.84% | 30.43% |
| Net Margin | -52.22% | -49.94% | -88.71% | -85.97% | -76.75% |
| Debt / Equity | - | - | - | 10.48x | 10.48x |
| Interest Coverage | -5.38x | -2.47x | -2.83x | -2.91x | -5.74x |
| FCF Conversion | 0.76x | 0.54x | 0.26x | 0.70x | 0.36x |
| Revenue Growth | - | 285.81% | 69.56% | -0.5% | -8.76% |
IVP Frequently Asked Questions
Inspire Veterinary Partners, Inc. (IVP) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Inspire Veterinary Partners, Inc. (IVP) reported $15.6M in revenue for fiscal year 2024.
Inspire Veterinary Partners, Inc. (IVP) saw revenue decline by 0.5% over the past year.
Inspire Veterinary Partners, Inc. (IVP) reported a net loss of $11.9M for fiscal year 2024.
Dividend & Returns
Inspire Veterinary Partners, Inc. (IVP) has a return on equity (ROE) of -3687.1%. Negative ROE indicates the company is unprofitable.
Inspire Veterinary Partners, Inc. (IVP) had negative free cash flow of $4.3M in fiscal year 2024, likely due to heavy capital investments.
Explore More IVP
Inspire Veterinary Partners, Inc. (IVP) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates